Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD

Conditions

• Pulmonary Disease, Chronic Obstructive

Interventions

• DRUG: BI 1744 CL 2 µg
• DRUG: BI 1744 CL 5 µg
• DRUG: BI 1744 CL 10 µg
• DRUG: Placebo

Sponsor

Boehringer Ingelheim